Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report
- PMID: 15119910
- DOI: 10.4088/jcp.v65n0406
Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report
Abstract
Background: Remission of illness in patients with major depressive disorder (MDD) is achieved in less than half of patients initially treated with medication. Electroconvulsive therapy (ECT) is another treatment option. We report the speed of response and remission rates in a cohort of depressed patients who received a course of acute-phase ECT in the initial phase of an ongoing multicenter randomized trial of continuation ECT versus pharmacotherapy.
Method: Patients with MDD according to DSM-IV criteria received bilateral ECT 3 times weekly. Prior to each treatment, a 24-item Hamilton Rating Scale for Depression (HAM-D-24) score was obtained by a clinical rater. Sustained response was defined as a > or = 50% reduction in baseline HAM-D-24 score for at least 2 and all subsequent measurement occasions. Remission was defined as HAM-D-24 scores of < or = 10 for at least the last 2 consecutive assessments. Data were collected from May 1997 through November 2000.
Results: Of the 253 patients who entered the study, 86% (N = 217) completed the acute course of ECT. Sustained response occurred in 79% of the sample, and remission occurred in 75% of the sample (N = 253); 34% (85/253) of patients achieved remission at or before ECT #6 (week 2), and 65% (164/253) achieved remission at or before ECT #10 (weeks 3-4). Over half (54%; 136/253) had an initial first response by ECT #3 (end of week 1).
Conclusion: ECT was associated with rapid response and remission in a high percentage of patients. ECT warrants early consideration in treatment algorithms for patients with MDD.
Similar articles
-
Electroconvulsive therapy and resistant depression: clinical implications of seizure threshold.J Clin Psychiatry. 1996 Jan;57(1):32-8. J Clin Psychiatry. 1996. PMID: 8543545 Clinical Trial.
-
Novel Augmentation Strategies in Major Depression.Dan Med J. 2017 Apr;64(4):B5338. Dan Med J. 2017. PMID: 28385173 Review.
-
Long-term naturalistic follow-up of patients with bipolar depression and mixed state treated with electroconvulsive therapy.J ECT. 2013 Sep;29(3):179-88. doi: 10.1097/YCT.0b013e3182887b7a. J ECT. 2013. PMID: 23899721
-
DSM melancholic features are unreliable predictors of ECT response: a CORE publication.J ECT. 2007 Sep;23(3):139-46. doi: 10.1097/yct.0b013e3180337344. J ECT. 2007. PMID: 17804986 Clinical Trial.
-
What was learned: studies by the consortium for research in ECT (CORE) 1997-2011.Acta Psychiatr Scand. 2014 Jun;129(6):417-26. doi: 10.1111/acps.12251. Epub 2014 Feb 12. Acta Psychiatr Scand. 2014. PMID: 24571807 Review.
Cited by
-
Structural neural plasticity evoked by rapid-acting antidepressant interventions.Nat Rev Neurosci. 2024 Nov 18. doi: 10.1038/s41583-024-00876-0. Online ahead of print. Nat Rev Neurosci. 2024. PMID: 39558048 Review.
-
Evaluating Anesthesia Practices, Patient Characteristics, and Outcomes in Electroconvulsive Therapy: A Two-Year Retrospective Study.J Clin Med. 2024 Oct 19;13(20):6253. doi: 10.3390/jcm13206253. J Clin Med. 2024. PMID: 39458203 Free PMC article.
-
A review of diffusion MRI in mood disorders: mechanisms and predictors of treatment response.Neuropsychopharmacology. 2024 Nov;50(1):211-229. doi: 10.1038/s41386-024-01894-3. Epub 2024 Jun 20. Neuropsychopharmacology. 2024. PMID: 38902355 Review.
-
Repetitive transcranial magnetic stimulation for residual depressive symptoms after electroconvulsive therapy in an elderly patient with treatment-resistant depression.PCN Rep. 2022 May 2;1(2):e11. doi: 10.1002/pcn5.11. eCollection 2022 Jun. PCN Rep. 2022. PMID: 38868645 Free PMC article. No abstract available.
-
A Case of Treatment-Resistant Depression Complicated by Traumatic Brain Injury and Seizure: Implications for Interventional Treatment and Psychiatric Training.Harv Rev Psychiatry. 2024 May-Jun 01;32(3):117-125. doi: 10.1097/HRP.0000000000000394. Harv Rev Psychiatry. 2024. PMID: 38728571 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources